American youth and young adults face persistent and chronic stressors, which have contributed to a mental health crisis in the United States. Four in 10 American high school students experience chronic feelings of sadness and hopelessness, 2 in 10 report suicidal ideation, and 1 in 10 attempt suicide. For adolescents and young adults, chronic stress translates to weathering, or wear and tear on the mind and body. Chronic stress in youth contributes to psychological distress, elevated allostatic load, and an elevated risk for chronic diseases and premature death. While the connection between chronic stress and health is well documented, few studies provide evidence on innovative, non-medication strategies to reduce stress and mitigate the consequences of chronic stress on psychological and physiological outcomes. Thus, there is a critical need to rigorously test interventions that prevent the negative influence of chronic stress on mental and physical health, beginning in adolescence. The specific aims of the study are to 1) Determine whether a community-engagement, peer-based behavioral intervention reduces depressive symptoms in adolescents and young adults, 2) Determine whether a community-engagement behavioral intervention lowers allostatic load scores in adolescents and young adults, and 3) Identify factors that help sustain or inhibit community-engagement and intervention effects for adolescents and young adults. To accomplish these aims, the team will conduct a phase II community-engaged, peer group-based, multi-component randomized behavioral clinical trial. We will collect psychological and physiological measures at baseline, then at 6-month intervals for 2 years post-community-engaged, skills training.
Age range
15 Years – 20 Years
Sex
ALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.
Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.
The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.
A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.
Depressive Symptoms
Timeframe: Time Frame: at baseline and then 0-1-, 6-, 12-, 18-, and 24- months post initial 5-day intervention.
Metabolic Syndrome
Timeframe: Time Frame: at baseline and then 6-, 12-, and 24- months post initial 5 day-intervention
Blood Pressure
Timeframe: Time Frame: at baseline and then 6-, 12-, and 24- months post initial 5 day-intervention.
Triglycerides
Timeframe: Time Frame: at baseline and then 6-, 12-, and 24- months post initial 5 day-intervention.
High-density lipoprotein
Timeframe: Time Frame: at baseline and then 6-, 12-, and 24- months post initial 5 day-intervention.
Glycosylated hemoglobin
Timeframe: Time Frame: at baseline and then 6-, 12-, and 24- months post initial 5 day-intervention.
Glucose
Timeframe: Time Frame: at baseline and then 6-, 12-, and 24- months post initial 5 day-intervention.
Insulin
Timeframe: Time Frame: at baseline and then 6-, 12-, and 24- months post initial 5 day-intervention.
Waist Circumference
Timeframe: Time Frame: at baseline and then 6-, 12-, and 24- months post initial 5 day-intervention.